Replies to post #509161 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Dr. Makary Would Be The Guy

He also mentioned that he and Anavex have already spoken to the FDA regarding A2-73 in a very preliminary Type C meeting again (emphasizing very preliminary).

The FDA person that needs to hear and learn about blarcamesine is Dr. Martin Makary, new FDA Commissioner. He has the power to make unique blarcamesine authorization protocols effective and functional.

[frrol]

He does come across well, and is considered credible and a KOL. He'll be helpful for the re-exam.

[Chemdeps]

That is exactly what I heard.

[123tom]

Could you ask Dr. Sabbagh if he thinks blarcamesine has about a 4% chance of approval? 😏
…. Asking for a frend